0001477932-16-011103.txt : 20160629 0001477932-16-011103.hdr.sgml : 20160629 20160629161252 ACCESSION NUMBER: 0001477932-16-011103 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160623 FILED AS OF DATE: 20160629 DATE AS OF CHANGE: 20160629 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Citius Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001506251 STANDARD INDUSTRIAL CLASSIFICATION: MOTOR VEHICLE PARTS & ACCESSORIES [3714] IRS NUMBER: 273425913 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11 COMMERCE DRIVE STREET 2: 1ST FLOOR CITY: CRANFORD STATE: NJ ZIP: 07016 BUSINESS PHONE: (908) 967-6676 MAIL ADDRESS: STREET 1: 11 COMMERCE DRIVE STREET 2: 1ST FLOOR CITY: CRANFORD STATE: NJ ZIP: 07016 FORMER COMPANY: FORMER CONFORMED NAME: Trail One, Inc. DATE OF NAME CHANGE: 20110314 FORMER COMPANY: FORMER CONFORMED NAME: TrailOne, Inc. DATE OF NAME CHANGE: 20101119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Holuka Eugene Myron CENTRAL INDEX KEY: 0001678292 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55532 FILM NUMBER: 161738960 MAIL ADDRESS: STREET 1: 11 COMMERCE DRIVE STREET 2: 11TH FLOOR CITY: CRANFORD STATE: NJ ZIP: 07016 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2016-06-23 0 0001506251 Citius Pharmaceuticals, Inc. CTXR 0001678292 Holuka Eugene Myron 11 COMMERCE DRIVE 11TH FLOOR CRANFORD NJ 07016 1 0 0 0 Options to Purchase Common Stock 0.001 Common Stock 36212 D Options to Purchase Common Stock 0.8 2016-06-23 4 A 0 200000 0.8 A 2026-06-23 Common Stock 200000 200000 D On April 14, 2014 the Reporting Person was granted a ten-year option to purchase 20,000 shares of LMB common stock at an exercise price of $0.001 per share. The option vests in 1/3 increments over a three year period commencing on the first anniversary of the date of the grant, or April 14, 2014. On March 30, 2015 the Issuer entered into that certain Agreement and Plan of Merger (the "Merger Agreement") by and among the Issuer, Citius LMB Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of the Issuer and Leonard-Meron Biosciences, Inc., a Delaware corporation ("LMB"). Pursuant to the Merger Agreement, the option was converted into an option to purchase 36,212 shares of the Issuer's common stock at a per share exercise price of $0.001. The option vests in 1/3 increments over a three year period with the first installment vesting on April 14, 2014. The options vest in full on the first anniversary of the date of grant. /s/ Erica B. Jackson, by power of attorney 2016-06-29